Notice of Intent to Publish a Funding Opportunity Announcement for Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial not allowed)

0
347

Opportunity ID: 321317
Opportunity Number: NOT-MH-19-043
Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial not allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.242
93.273
Eligible Applicants: State governments
County governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Oct 04, 2019
Last Updated Date: Oct 04, 2019
Estimated Synopsis Post Date: Jan 08, 2020
Fiscal Year: 2020
Award Ceiling:
Award Floor:
Estimated Total Program Funding:
Expected Number of Awards: 5
Description: The NIMH and NIAAA intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for research on the development of PET and SPECT tracers for molecular targets (e.g., receptors, intracellular messengers, disease-related proteins) that are implicated in mental disorders and alcohol abuse as tools to study disease pathophysiology and/or for assessing target engagement of potential therapeutic candidates. The objective of this FOA is to stimulate research in the identification and development of PET and SPECT probes for disorders of primary interest to the NIMH or NIAAA. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in January 8, 2020 with an expected application due date in February 5, 2020 . This FOA will utilize the R01 activity code. Details of the planned FOA are provided below.
Version: 1





Visit the Official Webpage For More Details on Notice of Intent to Publish a Funding Opportunity Announcement for Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial not allowed)

LEAVE A REPLY

Please enter your comment!
Please enter your name here